logo

For the Inventor, By the Inventor

Wuppertal, Germany

Theodor W Denzel

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodor W Denzel. Retrieved from https://idiyas.com/inventor/theodor-w-denzel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 106(Granted Patents)


Company Filing History:

goldMedal4 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 2002-2011

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2011-04-26),
2. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2008-05-20),
3. 6639082 - Methods for the preparation of biphenyl isoxazole sulfonamides (2003-10-28),
4. 6340752 - Deprotection and recrystallization processes (2002-01-22),

Title: Theodor W Denzel: Innovator in Diabetes Treatment

Introduction

Theodor W Denzel is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for diabetes. With a total of 4 patents to his name, Denzel's work has had a meaningful impact on medical science.

Latest Patents

Denzel's latest patents focus on methods of producing C-aryl glucoside SGLT2 inhibitors. These methods are crucial for the treatment of diabetes and related diseases. The patents detail the production of C-aryl glucoside SGLT2 inhibitors and their intermediates. Additionally, the C-aryl glucosides may be complexed with amino acid complex forming reagents, enhancing their therapeutic potential.

Career Highlights

Denzel is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has been instrumental in advancing innovative treatments for diabetes. His expertise in the field has positioned him as a key player in pharmaceutical research and development.

Collaborations

Denzel has collaborated with notable colleagues such as Prashant P Deshpande and Bruce A Ellsworth. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Theodor W Denzel's contributions to diabetes treatment through his innovative patents and collaborations highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…